Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
Cockatiel Keeps Owner Awake With Earth, Wind & Fire Performance
Meet Bruce: The Mysterious Cat With A Unique Coat
The Cat At This AirBnB Leads Guests On Memorable Hikes Along The Appalachian Trail
Woman Announces Her Passing On LinkedIn, Her Message Is Spreading Far And Wide
The World's Most Expensive Cow Sells For Over $4 Million
Mom Asks For Help After Husband Suggests The 'Worst Name Ever' For First Child
Teddy Has Had Enough! Baby Has Hilarious Reaction To 'Happy Birthday' Song
Simon & Garfunkel Sing 'Baby Got Back' Instead Of 'Sound Of Silence' In Hilarious Mashup
Dad Cries Tears Of Joy As Daughter Performs Perfect Gymnastics Routine To 'Never Grow Up'
These Flamingo's Dancing To 'Thriller' Is Guaranteed To Make Your Day
Wild Crow Becomes Little Boy's Self-Appointed Godfather